Insider Shareholders with Direct Ownership of Arrowhead Pharmaceuticals, Inc. (ARWR)
This section provides a comprehensive overview of the insiders with direct ownership of Arrowhead Pharmaceuticals, Inc. (ARWR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ARROWHEAD PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Christopher Richard Anzalone
Chief Executive Officer |
2,340,593 | 1,286,406 | 3,715,048 $93.1 Million | 33 |
Jan 31, 2024
Reduced 0.53%
|
|
Patrick O'Brien
COO and General Counsel |
420,000 | 213,990 | 464,385 $11.6 Million | 16 |
Jan 05, 2024
Reduced 2.67%
|
|
Kenneth Allen Myszkowski
Chief Financial Officer |
327,671 | 258,063 | 400,600 $10 Million | 16 |
Mar 06, 2024
Reduced 9.08%
|
|
James C Hamilton
Chief Discovery/Trans Medicine |
240,000 | 153,899 | 204,851 $5.14 Million | 16 |
Apr 01, 2024
Reduced 2.85%
|
|
Martin Javier San
Chief Medical Officer |
135,000 | 86,503 | 198,497 $4.98 Million | 7 |
Jan 05, 2024
Reduced 2.17%
|
|
Douglas B Given
Director |
39,409 | 64,511 | 129,711 $3.25 Million | 15 |
Jan 11, 2024
Reduced 0.84%
|
|
Tracie Oliver
Chief Commercial Officer |
75,500 | 18,393 | 127,107 $3.19 Million | 5 |
Jul 02, 2024
Reduced 6.88%
|
|
Michael S Perry
Director |
38,254 | 8,500 | 114,754 $2.88 Million | 6 |
Dec 15, 2023
Added 11.55%
|
|
James Hassard
Chief Commercial Officer |
0 | 19,250 | 105,750 $2.65 Million | 2 |
Jun 22, 2021
Reduced 3.31%
|
|
Mauro Ferrari
Director |
38,254 | 16,547 | 60,778 $1.52 Million | 7 |
Jan 11, 2024
Reduced 1.62%
|
|
William D. Waddill
Director |
38,254 | 18,384 | 47,870 $1.2 Million | 9 |
Jan 11, 2024
Reduced 2.64%
|
|
Lu Hongbo
Director |
3,000 | 0 | 33,680 $844,357 | 3 |
Mar 20, 2024
Added 2.88%
|
|
Marianne De Backer
Director |
24,267 | 9,500 | 31,267 $783,863 | 6 |
Jan 10, 2023
Added 20.1%
|
|
Victoria Vakiener
Director |
22,854 | 9,833 | 30,205 $757,239 | 6 |
May 02, 2024
Reduced 5.62%
|
|
Adeoye Y Olukotun
Director |
38,254 | 20,400 | 22,854 $572,949 | 7 |
Dec 15, 2023
Added 39.61%
|
|
Curt Bradshaw
Chief Scientific Officer |
0 | 31,250 | 0 $0 | 2 |
Nov 20, 2020
Reduced 100.0%
|